- Home
- SMMT vs RVTY Comparison
SMMT vs RVTY Comparison
Compare SMMT & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMMT
- RVTY
- Stock Information
- Founded
- SMMT 2003
- RVTY 1937
- Country
- SMMT United States
- RVTY United States
- Employees
- SMMT N/A
- RVTY N/A
- Industry
- SMMT Biotechnology: Pharmaceutical Preparations
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- SMMT Health Care
- RVTY Industrials
- Exchange
- SMMT Nasdaq
- RVTY Nasdaq
- Market Cap
- SMMT 14.5B
- RVTY 15.1B
- IPO Year
- SMMT N/A
- RVTY N/A
- Fundamental
- Price
- SMMT $18.31
- RVTY $109.52
- Analyst Decision
- SMMT Strong Buy
- RVTY Buy
- Analyst Count
- SMMT 4
- RVTY 16
- Target Price
- SMMT $34.75
- RVTY $129.40
- AVG Volume (30 Days)
- SMMT 2.1M
- RVTY 1.0M
- Earning Date
- SMMT 10-30-2024
- RVTY 11-04-2024
- Dividend Yield
- SMMT N/A
- RVTY 0.26%
- EPS Growth
- SMMT N/A
- RVTY N/A
- EPS
- SMMT N/A
- RVTY 2.06
- Revenue
- SMMT N/A
- RVTY $2,721,555,000.00
- Revenue This Year
- SMMT N/A
- RVTY $2.34
- Revenue Next Year
- SMMT N/A
- RVTY $5.58
- P/E Ratio
- SMMT N/A
- RVTY $52.34
- Revenue Growth
- SMMT N/A
- RVTY N/A
- 52 Week Low
- SMMT $1.88
- RVTY $86.30
- 52 Week High
- SMMT $33.89
- RVTY $129.50
- Technical
- Relative Strength Index (RSI)
- SMMT 41.16
- RVTY 28.31
- Support Level
- SMMT $19.01
- RVTY $118.98
- Resistance Level
- SMMT $22.53
- RVTY $120.85
- Average True Range (ATR)
- SMMT 1.45
- RVTY 4.43
- MACD
- SMMT -0.21
- RVTY -0.95
- Stochastic Oscillator
- SMMT 4.85
- RVTY 1.48
About SMMT Summit Therapeutics Inc.
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.